The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.
The wastewater analytics firm will work with the two government agencies to analyze samples from treatment plants across the US for SARS-CoV-2 viral elements.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.
The investment bank sees the potential for strong revenue growth over time as Oncocyte expands its product portfolio and launches new tests.
Last week, GenomeWeb's readers were most interested in Somalogic's news of having closed a $121 million Series A funding round.
The company's HCCscreen assay will be used in a liver cancer screening public health initiative, generating real-world data on the test's clinical validity and impact.
The company sells miniaturized mass spectrometers and microfluidic separations systems for use in applied markets and life science and drug research.
The next-generation sequencing-based panel comprises more than 50 genes and disorders known to cause hereditary anemias, such as pyruvate kinase deficiency.
The RT-PCR-based test was first authorized earlier this year for the detection of SARS-CoV-2 nucleic acid in specimens collected by a healthcare provider.
The test uses a targeted methylation sequencing panel to detect more than 50 cancer types across all stages and pinpoint a cancer's tissue of origin.
Twenty-nine new studies highlight how time in space affects the human body, including effects on telomeres, mitochondria, and more.
A team led by researchers at University College London studied mutations in almost 47,000 viral genomes collected from patients worldwide.
The company said it will use proceeds from the round, which was led by Casdin Capital, to expand and commercialize its SomaScan platform and SomaSignal tests.
An integrated proteogenomic analysis led to previously unappreciated treatment targets or prognostic markers in craniopharyngioma, high-grade glioma, and other tumor types.
Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.
In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.
Called direct infusion–shotgun proteome analysis, the approach uses ion mobility in place of liquid chromatography to enable higher-throughput experiments.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The FDA also reissued Emergency Use Authorizations for SARS-CoV-2 tests from Roche and Express Gene to reflect their permitted use with additional sample types.